4 completed. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
| Phase 1 | 1 | Completed 1 |
Follow Xention Ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study on the Effects of TA-8995 on Lp(a) in Subjects With Elevated Lp(a) TA-8995, Placebo - Elevated Lp(a) | Phase 1 / Phase 2 | Completed | Xention Ltd | 42 | 2014-09-01 | 2015-02-16 |
| A Study to Assess the Efficacy of XEN-D0501 in Reducing the Cough Frequency in Patients With Chronic Idiopathic Cough XEN-D0501, Placebo - Chronic Idiopathic Cough | Phase 2 | Completed | Xention Ltd | 18 | 2014-07-01 | 2015-07-15 |
| A Study to Assess the Efficacy of XEN-D0501 in Reducing the Cough Frequency in Patients With COPD XEN-D0501, Placebo - Chronic Obstructive Pulmonary Disease | Phase 2 | Completed | Xention Ltd | 27 | 2014-02-01 | 2015-07-15 |
| TA-8995: Its Use in Patients With Mild Dyslipidaemia (TULIP) TA-8995, Atorvastatin, Rosuvastatin - Dyslipidemia | Phase 2 | Completed | Xention Ltd | 364 | 2013-08-01 | 2014-08-21 |
Dyslipidemias (1) · Pulmonary Disease, Chronic Obstructive (1)
TA-8995 (2) · Atorvastatin (1) · Rosuvastatin Calcium (1)
Denmark (2) · United Kingdom (2) · Ireland (1) · Netherlands (1)